advertisement
Advances in Therapy 21
Showing records 1 to 21 | Display all abstracts in Advances in Therapy92099 Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
Araie M
Advances in Therapy 2021; 38: 1757-1775
92175 Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
Harasymowycz P
Advances in Therapy 2021; 38: 3019-3031
92121 Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study
Ansari E
Advances in Therapy 2021; 38: 2990-3002
92099 Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
Sugiyama K
Advances in Therapy 2021; 38: 1757-1775
92175 Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
Hutnik C
Advances in Therapy 2021; 38: 3019-3031
92121 Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study
Pavicic-Astalos J
Advances in Therapy 2021; 38: 2990-3002
92099 Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
Aso K
Advances in Therapy 2021; 38: 1757-1775
92121 Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study
Ayan F
Advances in Therapy 2021; 38: 2990-3002
92175 Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
Rouland JF
Advances in Therapy 2021; 38: 3019-3031
92121 Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study
King AJ
Advances in Therapy 2021; 38: 2990-3002
92099 Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
Kanemoto K
Advances in Therapy 2021; 38: 1757-1775
92175 Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
Negrete FJM; Economou MA
Advances in Therapy 2021; 38: 3019-3031
92099 Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
Kothapalli K
Advances in Therapy 2021; 38: 1757-1775
92121 Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study
Kinsella M; Ng E
Advances in Therapy 2021; 38: 2990-3002
92175 Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
Denis P
Advances in Therapy 2021; 38: 3019-3031
92099 Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
Kopczynski C
Advances in Therapy 2021; 38: 1757-1775
92121 Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study
Nita A
Advances in Therapy 2021; 38: 2990-3002
92175 Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
Baudouin C
Advances in Therapy 2021; 38: 3019-3031
92099 Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
Senchyna M
Advances in Therapy 2021; 38: 1757-1775
92121 Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study
Advances in Therapy 2021; 38: 2990-3002
92099 Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
Hollander DA
Advances in Therapy 2021; 38: 1757-1775
